194 related articles for article (PubMed ID: 32859615)
21. Effects of synbiotic supplementation on serum adiponectin and inflammation status of overweight and obese breast cancer survivors: a randomized, triple-blind, placebo-controlled trial.
Raji Lahiji M; Zarrati M; Najafi S; Yazdani B; Cheshmazar E; Razmpoosh E; Janani L; Raji Lahiji M; Shidfar F
Support Care Cancer; 2021 Jul; 29(7):4147-4157. PubMed ID: 33404812
[TBL] [Abstract][Full Text] [Related]
22. Effects of exercise during adjuvant chemotherapy on breast cancer outcomes.
Courneya KS; Segal RJ; McKenzie DC; Dong H; Gelmon K; Friedenreich CM; Yasui Y; Reid RD; Crawford JJ; Mackey JR
Med Sci Sports Exerc; 2014 Sep; 46(9):1744-51. PubMed ID: 24633595
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory Marker Changes in Postmenopausal Women after a Year-long Exercise Intervention Comparing High Versus Moderate Volumes.
Friedenreich CM; O'Reilly R; Shaw E; Stanczyk FZ; Yasui Y; Brenner DR; Courneya KS
Cancer Prev Res (Phila); 2016 Feb; 9(2):196-203. PubMed ID: 26603740
[TBL] [Abstract][Full Text] [Related]
24. Exercise intensity and markers of inflammation during and after (neo-) adjuvant cancer treatment.
Schauer T; Mazzoni AS; Henriksson A; Demmelmaier I; Berntsen S; Raastad T; Nordin K; Pedersen BK; Christensen JF
Endocr Relat Cancer; 2021 Mar; 28(3):191-201. PubMed ID: 33608485
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study.
Yam C; Esteva FJ; Patel MM; Raghavendra AS; Ueno NT; Moulder SL; Hess KR; Shroff GS; Hodge S; Koenig KH; Chavez Mac Gregor M; Griner RL; Yeung SJ; Hortobagyi GN; Valero V
Invest New Drugs; 2019 Apr; 37(2):345-351. PubMed ID: 30610588
[TBL] [Abstract][Full Text] [Related]
26. Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study.
Villaseñor A; Ambs A; Ballard-Barbash R; Baumgartner KB; McTiernan A; Ulrich CM; Neuhouser ML
Breast Cancer Res Treat; 2011 Sep; 129(2):485-94. PubMed ID: 21455669
[TBL] [Abstract][Full Text] [Related]
27. Exercise training, circulating cytokine levels and immune function in cancer survivors: A meta-analysis.
Khosravi N; Stoner L; Farajivafa V; Hanson ED
Brain Behav Immun; 2019 Oct; 81():92-104. PubMed ID: 31454519
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
[TBL] [Abstract][Full Text] [Related]
29. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
[No Abstract] [Full Text] [Related]
30. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.
Ahmad T; Fiuzat M; Mark DB; Neely B; Neely M; Kraus WE; Kitzman DW; Whellan DJ; Donahue M; Zannad F; Piña IL; Adams K; O'Connor CM; Felker GM
Am Heart J; 2014 Feb; 167(2):193-202.e1. PubMed ID: 24439980
[TBL] [Abstract][Full Text] [Related]
31. Effects of Diet and Exercise-Induced Weight Loss on Biomarkers of Inflammation in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Bruinsma TJ; Dyer AM; Rogers CJ; Schmitz KH; Sturgeon KM
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1048-1062. PubMed ID: 33737299
[TBL] [Abstract][Full Text] [Related]
32. Building a physical activity intervention into clinical care for breast and colorectal cancer survivors in Wisconsin: a randomized controlled pilot trial.
Cadmus-Bertram L; Tevaarwerk AJ; Sesto ME; Gangnon R; Van Remortel B; Date P
J Cancer Surviv; 2019 Aug; 13(4):593-602. PubMed ID: 31264183
[TBL] [Abstract][Full Text] [Related]
33. Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program.
de Groot M; Marrero D; Mele L; Doyle T; Schwartz F; Mather KJ; Goldberg R; Price DW; Ma Y; Knowler WC;
Psychosom Med; 2018; 80(2):167-173. PubMed ID: 29016549
[TBL] [Abstract][Full Text] [Related]
34. Dose-dependent effect of aerobic exercise on inflammatory biomarkers in a randomized controlled trial of women at high risk of breast cancer.
Haley JS; Hibler EA; Zhou S; Schmitz KH; Sturgeon KM
Cancer; 2020 Jan; 126(2):329-336. PubMed ID: 31568587
[TBL] [Abstract][Full Text] [Related]
35. Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.
Goldberg RB; Temprosa MG; Mather KJ; Orchard TJ; Kitabchi AE; Watson KE;
Diabetes Care; 2014 Aug; 37(8):2253-60. PubMed ID: 24824548
[TBL] [Abstract][Full Text] [Related]
36. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
37. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
38. Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults.
Malin SK; Nightingale J; Choi SE; Chipkin SR; Braun B
Obesity (Silver Spring); 2013 Jan; 21(1):93-100. PubMed ID: 23505172
[TBL] [Abstract][Full Text] [Related]
39. Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome.
Bulcão C; Ribeiro-Filho FF; Sañudo A; Roberta Ferreira SG
Am J Cardiovasc Drugs; 2007; 7(3):219-24. PubMed ID: 17610348
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer.
Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Bojesen SE; Pfeiffer P; Bjerregaard JK; Nielsen SE; Andersen F; Holländer NH; Yilmaz MK; Rasmussen LS; Johansen JS
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):176-184. PubMed ID: 31685562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
